Immunology and Cancer Biology The BMP9/10-ALK1-Endoglin Pathway as a Target of Anti-Angiogenic Therapy in CancerDownload The-BMP910-ALK1-Endoglin-Pathway-as-a-Target-of-Anti-Angiogenic-Therapy-in-Cancer Share: Newer Post Study of the Genetic Variants in BRCA1/2 and Non-BRCA Genes in a Population-Based Cohort of 2155 Breast/Ovary Cancer Patients, Including 443 Triple-Negative Breast Cancer Patients, in Argentina Older Post BMP9, but Not BMP10, Acts as a Quiescence Factor on Tumor Growth, Vessel Normalization and Metastasis in a Mouse Model of Breast Cancer
